MedPath

Culturally Adapted Psychoeducation (CaPE) for Bipolar Disorders in Nigeria

Not Applicable
Not yet recruiting
Conditions
Bipolar Disorder
Interventions
Behavioral: Culturally adapted Psychoeducation (CaPE)
Registration Number
NCT05721196
Lead Sponsor
Nottingham Trent University
Brief Summary

Bipolar disorders are chronic mental health disorders that often result in functional impairment, constituting a significant disease burden. It also accounts for seven per cent of disability-adjusted life years caused by mental disorders. Four out of ten persons with a probable diagnosis of bipolar disorders received no mental health care within the preceding twelve months. Compared to the general population, individuals with bipolar disorders tend to have a significantly higher rate of associated suicide mortality. Within the last decade, these mortality rates have substantially increased, suggesting the need for targeted research to address the unresolved needs of individuals suffering from bipolar disorders. A recent meta-analysis found that compared to the general population, bipolar patients had reduced life expectancy with about thirteen years of potential life loss.

Bipolar disorders are historically under-researched compared to other mental health disorders, especially in Sub-Saharan Africa and Nigeria. Our recent study on bipolar disorders in Nigeria provided insight into contextual knowledge and beliefs about bipolar disorders, including the lived experiences of patients with bipolar disorders, their caregivers, and clinicians in Nigeria. The study recommended culturally adapted psychosocial intervention for bipolar patients, hence the proposed research.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • diagnosis of DSM IV bipolar affective disorder
  • currently euthymic (BDI < 12 and YMRS < 8)
  • age 18-65 years, participants engaged with the mental health services for the preceding 6 months
  • able to give written informed consent
  • resident of the trial catchment area and
  • the ability to speak English.
Exclusion Criteria
  • severe cognitive impairment
  • currently experiencing relapse (mania, hypomania, mixed or depressive)
  • being actively suicidal
  • the presence of any comorbid psychiatric illness such as substance misuse or alcohol dependence according to DSM IV criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment as Usual (TaU)Treatment as Usual (TaU)-
Culturally adapted Psychoeducation (CaPE)Culturally adapted Psychoeducation (CaPE)-
Primary Outcome Measures
NameTimeMethod
Pain reductionChange is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Patients' pain reduction would be assessed by the Visual Analogue Scale. For example, 0 = No pain and 10 = worst pain.

Secondary Outcome Measures
NameTimeMethod
Medication adherenceChange is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Medication adherence would be assessed using the Morisky measure of medication adherence survey

Quality of lifeChange is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Quality of life would be assessed using the Health-related quality of life was also measured using EuroQoL (EQ-5D)

Bipolar knowledge and attitudeChange is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Bipolar knowledge and attitude would be assessed using the Bipolar Knowledge \& attitude questionnaire

Severity of mood symptomsChange is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Severity of mood symptoms would be assessed using the Young Mania Rating Scale (YMRS) or Beck's Depression Inventory

© Copyright 2025. All Rights Reserved by MedPath